Ayana Jordan
New York University, NY·Public Health & Epidemiology
Overdose deaths in the United States topped 100,000 in 2023. Some neighborhoods, called "hotspots," still carry a far heavier burden than the national average.
- Fields
Public Health & Epidemiology
Medicine & Clinical Research
Psychology
- Topics
overdose prevention
substance use disorder
people who use drugs
- Grants
- 1 known grant, through Aug 2027
What they work on
- Test whether a mobile intervention, in which a community health representative screens eight life areas and links people to services, keeps 200 people who use drugs engaged in safety services better than usual care.
- Assess whether the integrated intervention improves access to and retention in medication for addiction treatment (MAT) among people living in high-overdose "hotspot" areas.
- Describe the current standard of care in overdose hotspots served by two mobile safety-service organizations, to help refine overdose prevention strategies.
More about the research
New York City and New Haven have had some of the highest and rising overdose rates for years. Effective treatment exists, along with safety services that reduce drug-related harm. Yet people who use drugs (PWUD) in hotspots are less likely to receive these services or to stay in medication for addiction treatment (MAT). They also face barriers to everyday needs such as housing and legal help.
Why it matters
Overdose deaths remain highest in a few hard-hit neighborhoods. A mobile, low-barrier program that connects people who use drugs to addiction treatment, housing, legal aid and mental health care could become a replicable model. Public health programs could use it to reduce overdose deaths and drug-related illness in high-risk communities such as those in New York City and New Haven.
Known grants
From NIH and NSF research grants. Labs often have other funding we can't see.
Closest labs
Ayesha Appa
University of California-San Francisco, CA·Medicine & Clinical Research·Early-career
Test the feasibility, acceptability and early effectiveness of long-acting injectable naltrexone, an opioid-blocking drug, for preventing opioid overdose in people who use stimulants, through a randomized trial against a standard harm-reduction bundle.
Susan Sherman
Johns Hopkins University, MD·Public Health & Epidemiology
Adapt Mobile SPARC outreach services for women who use drugs by identifying factors that help or hinder service use, through in-depth interviews with 40 women and 5 staff members.
Beth Meyerson
University of Arizona, AZ·Public Health & Epidemiology
Adapt the four MPACT components (staff trauma-informed training, trauma navigation, clinic self-assessment and reflective supervision) for opioid treatment programs through a participatory planning process with providers, patients and people with lived drug use experience.
The school
New York University: 72 labs on PI Pages, $1.5B a year on research, 540 research doctorates a year.
Reach out
A start for your email. Fill in the brackets.